Comparison between Esconet Technologies IPO and Zenith Drugs IPO.
Esconet Technologies IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Zenith Drugs IPO is a SME Bookbuilding proposed to list at NSE SME.
| Esconet Technologies IPO | Zenith Drugs IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Corporate Capitalventures Pvt.Ltd. | Gretex Corporate Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | Gretex Share Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Esconet Technologies IPO is up to ₹26.75 Cr whereas the issue size of the Zenith Drugs IPO is up to ₹33.94 Cr. The final issue price of Esconet Technologies IPO is ₹84.00 per share and of Zenith Drugs IPO is ₹79.00 per share.
| Esconet Technologies IPO | Zenith Drugs IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | ₹75.00 per share |
| Issue Price (Upper) | ₹84.00 per share | ₹79.00 per share |
| Issue Price (Final) | ₹84.00 per share | ₹79.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1600 shares |
| Fresh Issue Size | 31,84,000 shares | 42,96,000 shares |
| Fresh Issue Size (Amount) | up to ₹26.75 Cr | up to ₹33.94 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 31,84,000 shares | 42,96,000 shares |
| Issue Size Total (Amount) | up to ₹26.75 Cr | up to ₹33.94 Cr |
Esconet Technologies IPO opens on Feb 16, 2024, while Zenith Drugs IPO opens on Feb 19, 2024. The closing date of Esconet Technologies IPO and Zenith Drugs IPO is Feb 20, 2024, and Feb 22, 2024, respectively.
| Esconet Technologies IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Bid Date | Feb 15, 2024 | Feb 16, 2024 |
| Issue Open | Feb 16, 2024 | Feb 19, 2024 |
| Issue Close | Feb 20, 2024 | Feb 22, 2024 |
| Basis Of Allotment (Tentative) | Feb 21, 2024 | Feb 23, 2024 |
| Initiation of Refunds (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Credit of Share (Tentative) | Feb 22, 2024 | Feb 26, 2024 |
| Listing date (Tentative) | Feb 23, 2024 | Feb 27, 2024 |
| Anchor Lockin End date 1 | Mar 22, 2024 | Mar 24, 2024 |
| Anchor Lockin End date 2 | May 21, 2024 | May 23, 2024 |
Esconet Technologies IPO P/E ratio is 24.87, as compared to Zenith Drugs IPO P/E ratio of 18.4.
| Esconet Technologies IPO | Zenith Drugs IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Esconet Technologies Limited Financial Information (Restated Consolidated)
| Zenith Drugs Limited Financial Information (Restated Consolidated)Zenith Drugs Limited's revenue increased by 24.85% and profit after tax (PAT) rose by 64.7% between the financial year ending with March 31, 2023 and March 31, 2022.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 89.18 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 64.94 | 69.98 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 24.87 | 18.4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹103.82 Cr. | ₹135.48 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 75.54% | 35.13% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 59.11% | 37.29% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.99 | 1.51 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹39.63 | ₹4.29 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 54.83% | 29.88% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Esconet Technologies IPO Retail Individual Investors (RII) are offered 11,15,200 shares while in Zenith Drugs IPO retail investors are offered 11,15,200 shares. Qualified Institutional Buyers (QIB) are offered 6,36,800 shares in Esconet Technologies IPO and 8,59,200 shares in Zenith Drugs IPO.
| Esconet Technologies IPO | Zenith Drugs IPO | |
|---|---|---|
| Anchor Investor Reserveration | 9,53,600 shares | 12,88,000 shares |
| Market Maker Reserveration | 1,76,000 shares | 8,52,800 shares |
| QIB | 6,36,800 shares | 8,59,200 shares |
| NII | 4,78,400 shares | 6,44,800 shares |
| RII | 11,15,200 shares | 15,04,000 shares |
| Employee | ||
| Others | ||
| Total | 31,84,000 shares | 42,96,000 shares |
Esconet Technologies IPO subscribed 507.24x in total, whereas Zenith Drugs IPO subscribed 179.18x.
| Esconet Technologies IPO | Zenith Drugs IPO | |
|---|---|---|
| QIB (times) | 156.02x | 106.72x |
| NII (times) | 868.05x | 368.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 553.02x | 139.28x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 507.24x | 179.18x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
